These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9576017)

  • 21. Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals.
    Mejia AA; Nakamura T; Itoh M; Hatazawa J; Ishiwata K; Ido T; Matsumoto M; Watabe H; Watanuki S; Seo S
    J Radiat Res; 1991 Sep; 32(3):243-61. PubMed ID: 1838773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation dose to technicians per nuclear medicine procedure: comparison between technetium-99m, gallium-67, and iodine-131 radiotracers and fluorine-18 fluorodeoxyglucose.
    Chiesa C; De Sanctis V; Crippa F; Schiavini M; Fraigola CE; Bogni A; Pascali C; Decise D; Marchesini R; Bombardieri E
    Eur J Nucl Med; 1997 Nov; 24(11):1380-9. PubMed ID: 9371871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102.
    Verschuer JD; Towson J; Eberl S; Katsifis A; Henderson D; Lam P; Wen L; Loc'h C; Mattner F; Thomson S; Mohamed A; Fulham MJ
    Nucl Med Biol; 2012 Jul; 39(5):742-53. PubMed ID: 22300959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positron emission tomography and radiation exposure].
    Schober O; Lottes G
    Nuklearmedizin; 1994 Oct; 33(5):174-7. PubMed ID: 7997373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are restrictions to behaviour of patients required following fluorine-18 fluorodeoxyglucose positron emission tomographic studies?
    Cronin B; Marsden PK; O'Doherty MJ
    Eur J Nucl Med; 1999 Feb; 26(2):121-8. PubMed ID: 9933345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation dose rates from patients undergoing PET: implications for technologists and waiting areas.
    Benatar NA; Cronin BF; O'Doherty MJ
    Eur J Nucl Med; 2000 May; 27(5):583-9. PubMed ID: 10853815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the radiation dose in man due to 6-[18F]fluoro-L-dopa.
    Harvey J; Firnau G; Garnett ES
    J Nucl Med; 1985 Aug; 26(8):931-5. PubMed ID: 3928836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 400 MBq of 18F-FDG: one size no longer fits all?
    McMeekin H; Wagner T; Burniston M; McCool D
    Nucl Med Commun; 2014 Jul; 35(7):781-2. PubMed ID: 24878880
    [No Abstract]   [Full Text] [Related]  

  • 29. [Development of 18F-FDG ([F-18]-2-fluoro-2-deoxy-D-glucose) injection for imaging of tumor reflecting glucose metabolism--results of preclinical studies].
    Ino S; Shimada T; Kanagawa M; Suzuki N; Kondo S; Shirakami Y; Ito O; Kato-Azuma M
    Kaku Igaku; 1999 Jul; 36(5):467-76. PubMed ID: 10466310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 1: Diagnostic procedures].
    Sudbrock F; Boldt F; Kobe C; Eschner W; Schicha H
    Nuklearmedizin; 2008; 47(6):267-74. PubMed ID: 19057801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of 18F gaseous releases during the production of 18F-fluorodeoxyglucose.
    Kleck JH; Benedict SH; Cook JS; Birdsall RL; Satyamurthy N
    Health Phys; 1991 May; 60(5):657-60. PubMed ID: 2019496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey.
    Murano T; Minamimoto R; Senda M; Uno K; Jinnouchi S; Fukuda H; Iinuma T; Tsukamoto E; Terauchi T; Yoshida T; Oku S; Nishizawa S; Ito K; Oguchi K; Kawamoto M; Nakashima R; Iwata H; Inoue T
    Ann Nucl Med; 2011 Nov; 25(9):657-66. PubMed ID: 21720777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of induced radionuclides in replacement parts and liquid wastes in a medical cyclotron solely used for production of 18F for [18F]FDG.
    Mochizuki S; Ishigure N; Ogata Y; Kobayashi T
    Appl Radiat Isot; 2013 Apr; 74():137-43. PubMed ID: 23419430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of radiation dose received by the radiation worker during F-18 FDG injection process.
    Jha AK; Zade A; Rangarajan V
    Indian J Nucl Med; 2011 Jan; 26(1):11-3. PubMed ID: 21969773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of the chromosomal radiation damage induced by labelling of leukocytes with [18F]FDG.
    Miñana E; Roldán M; Chivato T; Martínez T; Fuente T
    Nucl Med Biol; 2015 Sep; 42(9):720-3. PubMed ID: 26025178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimates of the effective dose equivalent, HE, in positron emission tomography studies.
    Huda W; Sandison GA
    Eur J Nucl Med; 1990; 17(3-4):116-20. PubMed ID: 2279491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in the amount of fluorine-18 fluorodeoxyglucose excreted in urine measured from oncology patients during PET/computed tomography imaging.
    Soliman K; Alenezi A; Alqahtani S
    Nucl Med Commun; 2016 Sep; 37(9):992-6. PubMed ID: 27115066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of Radiation Exposure to Patients and Professionals by Reducing the Administered Activity of 18F-Fluorodeoxyglucose in a Positron-emission Tomography/Computed Tomography Study.
    Mithun S; Jha AK; Puranik AD; Monteiro P; Shah S; Agarwal A; Purandare NC; Rangarajan V
    Indian J Nucl Med; 2018; 33(1):6-9. PubMed ID: 29430107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measurement of radiation exposure to a PET institution driver from patients injected with FDG].
    Nakamura F; Kanno T; Okada H; Yoshikawa E; Andou I; Futatsubashi M; Shinke T; Ouchi Y; Torizuka T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Aug; 62(8):1105-10. PubMed ID: 16957665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of the Leakage Radiation Dose Rate from an Auto Infusion Device in
    Takada K; Kondo M; Furukawa M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Aug; 79(8):818-823. PubMed ID: 37344397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.